Investigating how the immune response to polyethylene glycol affects its use in medical implants
Effects of Poly(ethylene glycol) Immunogenicity on Implant Biocompatibility
This study is looking at how people's immune systems react to a common material called polyethylene glycol (PEG), which is used in many medical devices and treatments, to see if having antibodies against it affects how safe and effective these PEG-based products are, and it involves testing this in mice.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas Engineering Experiment Station NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10866592 on NIH RePORTER |
What this research studies
This research explores the immune response to polyethylene glycol (PEG), a material commonly used in medical devices and drug delivery systems. It aims to understand how the presence of antibodies against PEG, which affect a significant portion of the population, impacts the biocompatibility of PEG-based hydrogels. The study involves implanting PEG hydrogels in mice and assessing the host's immune response over time using various scientific techniques. By comparing responses in mice with and without anti-PEG antibodies, the research seeks to fill a critical knowledge gap regarding the safety and effectiveness of PEG in medical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may require medical implants or drug delivery systems that utilize PEG-based materials.
Not a fit: Patients who do not require medical implants or are not affected by PEG-related therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved safety and effectiveness of PEG-based medical devices for patients.
How similar studies have performed: While PEG is widely used, this specific investigation into its immunogenicity and impact on biocompatibility is relatively novel and has not been extensively studied.
Where this research is happening
College Station, United States
- Texas Engineering Experiment Station — College Station, United States (Active)
Researchers
- Principal investigator: Alge, Daniel — Texas Engineering Experiment Station
- Study coordinator: Alge, Daniel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.